Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report
Olav Toai Duc Nguyen(Norwegian University of Science and Technology), Oluf Dimitri Røe(Norwegian University of Science and Technology), Cecilie Bergseth(Levanger Hospital), Ane Karoline Stræte Røttereng(Levanger Hospital), Ganna Surzhykova Westvik(Levanger Hospital), Elisabeth Kvelstad Hallem(Levanger Hospital), Stein Sundstrøm(Haukeland University Hospital), Mona Røli Melhus(Levanger Hospital)
Cited by 16
Related Papers
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
|Journal of Clinical Oncology|2018|229
Shortlasting, Unilateral Neuralgiform Headache Attacks with Conjunctival Injection, Tearing, Sweating, and Rhinorrhea
|Cephalalgia|1989|226
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
|European Respiratory Review|2015|188
Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer
|Clinical Cancer Research|2012|140